GLP-1 medication can be prescribed for weight management in adults with BMIs of 30 or over or with BMIs of 27 or over with at least one weight-related condition (hypertension, type 2 diabetes, obstructive sleep apnea, etc.)
Once-weekly semaglutide produced sustained, clinically meaningful weight loss in people with obesity. (Wilding, New England Journal of Medicine )
Patients with Hashimoto's typically present with symptoms of hypothyroidism including fatigue, weight gain, cold intolerance, constipation, dry skin, hair loss, and cognitive difficulties such as poor concentration or memory problems
Pulmonary oxalate deposition associated with Aspergillus niger infection
Retatrutide is administered as a weekly subcutaneous injection
Slouha E, Patel B, Mohamed A, Razeq Z, Clunes LA, Kollias TF